527 frailty and multimorbidity in type 2 diabetes: a uk biobank analysis
ConclusionAssessment of frailty/multimorbidity should be embedded within routine management of middle-aged and older people with T2D. Method of identification as well as features such as age impact baseline risk and should influence clinical decisions (e.g. glycaemic control).
Source: Age and Ageing - Category: Geriatrics Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Geriatrics | Heart | Orthopaedics